SynthesisBMJ open2017

Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis.

Hung-Wei Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.